序号 |
标题 |
次数 |
作者 |
发布时间 |
75196 |
Tat-DOTA,DOTA-TAT(48-60),DOTA偶联细胞穿膜肽TAT |
139 |
h |
2024-12-13 |
75197 |
Cl-C6-PEG4-NHCO-C3-NHS,氯-C6--四聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
112 |
kx |
2024-12-13 |
75198 |
dysprosium-DOTA-PAMAM |
93 |
h |
2024-12-13 |
75199 |
Cl-C6-PEG3-NHCO-C3-NHS,氯-C6--三聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
137 |
kx |
2024-12-13 |
75200 |
Y-DOTA-TOC,CAS:293295-66-6 |
91 |
h |
2024-12-13 |
75201 |
DOTA-MAL-Cys39-exendin-4 |
126 |
h |
2024-12-13 |
75202 |
DO3A叔丁酯,CAS: 122555-91-3 |
242 |
h |
2024-12-13 |
75203 |
1202761-21-4,Biotinyl-NH-PEG3-C3-amido-C3-COOH |
121 |
kx |
2024-12-13 |
75204 |
(m-PEG4)2-C-C3-Br |
110 |
kx |
2024-12-13 |
75205 |
1,1,4,4,7,7-六(1,1-二甲基乙基)10,10-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸酯 |
166 |
h |
2024-12-13 |
75206 |
二乙酰氧二辛基锡盐,CAS:17586-94-6 |
129 |
h |
2024-12-13 |
75207 |
二苯基环辛炔-聚乙二醇-大环配体 |
99 |
h |
2024-12-13 |
75208 |
Azide-PEG11-CH2CH2CH2-COOtBu,叠氮-十一聚乙二醇-C3-叔丁酯 |
119 |
kx |
2024-12-13 |
75209 |
(S)-4-(4-(3-((4-((2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL) |
131 |
h |
2024-12-13 |
75210 |
DOTA四乙酸酯,CAS: 825625-07-8 |
200 |
h |
2024-12-13 |
75211 |
Boc-NH-PEG7-C3-acid,氨基叔丁酯-七聚乙二醇-C3-酸 |
86 |
kx |
2024-12-13 |
75212 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid |
110 |
h |
2024-12-13 |
75213 |
2731015-03-3,Boc-NH-PEG1-C3-acid,氨基叔丁酯-一聚乙二醇-C3-酸 |
106 |
kx |
2024-12-13 |
75214 |
Azide-PEG6-CH2CH2CH2-COOtBu,叠氮-六聚乙二醇-C3-叔丁酯 |
84 |
kx |
2024-12-13 |
75215 |
APN-C3-PEG5-acid, APN-C3-五聚乙二醇-羧酸 |
85 |
kx |
2024-12-13 |
75216 |
Pomalidomide-C3-NH2 hydrochloride的主要结构与功能基团 |
107 |
kx |
2024-12-13 |
75217 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, α-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl)ester,(αR)- |
120 |
h |
2024-12-13 |
75218 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid |
83 |
h |
2024-12-13 |
75219 |
Azide-C3-Iodoacetamide的应用领域 |
83 |
kx |
2024-12-13 |
75220 |
CAS: 1161883-51-7,Propargyl-PEG5-CH2CO2-NHS |
120 |
WYQ |
2024-12-13 |
75221 |
CAS: 1429934-37-1,Propargyl-PEG5-CH2CO2H |
87 |
WYQ |
2024-12-13 |
75222 |
CAS:1610950-41-8,DOTA-甲基四嗪 |
87 |
h |
2024-12-13 |
75223 |
CAS: 1694731-93-5,Propargyl-PEG4-CH2CO2H |
70 |
WYQ |
2024-12-13 |
75224 |
CAS: 141282-35-1,Amino-PEG5-CH2CO2H(氨基-五聚乙二醇-乙酸) |
88 |
WYQ |
2024-12-13 |
75225 |
2768332-86-9,FmocNH-C2-NHCO-PC-NHCO-C4-COOH,N-芴甲氧羰基-C2-酰胺-PC-酰胺-C4-羧酸 |
79 |
kx |
2024-12-13 |
75226 |
CAS:1345034-50-5,DOTA-(COOt-Bu)3 |
79 |
h |
2024-12-13 |
75227 |
CAS: 195071-49-9,Amino-PEG4-CH2CO2H(氨基-四聚乙二醇-乙酸) |
83 |
WYQ |
2024-12-13 |
75228 |
10-[2-[(3,5-Dicarboxyphenyl)amino]-2-oxoethyl]-DOTA(HCl salt) |
79 |
h |
2024-12-13 |
75229 |
CAS: 134978-99-7,Amino-PEG3-CH2CO2H(氨基-三聚乙二醇-乙酸) |
87 |
WYQ |
2024-12-13 |
75230 |
2138439-53-7,(S,R,S)-AHPC-C4-NH2 |
101 |
kx |
2024-12-13 |
75231 |
FmocNH-PEG3-CH2CH2NH2 中文名称:Fmoc-氨基-三聚乙二醇-乙二胺 |
177 |
WYQ |
2024-12-13 |
75232 |
Biotin-PEG2-CH2-aldehyde 中文名称:生物素-二聚乙二醇-亚甲基-醛基 |
98 |
WYQ |
2024-12-13 |
75233 |
2172819-74-6,(S,R,S)-AHPC-C4-COOH,VH 032 酰胺-烷基C4-酸 |
82 |
kx |
2024-12-13 |
75234 |
CAS: 112247-65-1,Biotin-NH-CH2CH2-S-S-Pyr |
92 |
WYQ |
2024-12-13 |
75235 |
CAS: 2100306-55-4,Propargyl-PEG1-CH2CO2tBu(炔丙基-PEG1-乙酸叔丁酯) |
82 |
WYQ |
2024-12-13 |
75236 |
Me-Diazirine-C4-Br的主要组成与功能基团 |
108 |
kx |
2024-12-13 |
75237 |
CAS: 2098489-63-3,Propargyl-PEG5-CH2CO2tBu(炔丙基-PEG5-乙酸叔丁酯) |
82 |
WYQ |
2024-12-13 |
75238 |
CAS: 888010-02-4,Propargyl-PEG4-CH2CO2tBu(炔丙基-PEG4-乙酸叔丁酯) |
91 |
WYQ |
2024-12-13 |
75239 |
TCO-PEG3-CH2-aldehyde 中文名称:TCO-三聚乙二醇-亚甲基-醛基 |
138 |
WYQ |
2024-12-13 |
75240 |
10,10-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸],盐酸盐 |
174 |
h |
2024-12-13 |